These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 27633510

  • 21. Vascular endothelial growth factor downregulates apolipoprotein M expression by inhibiting Foxa2 in a Nur77-dependent manner.
    Hu YW, Zheng L, Wang Q, Zhong TY, Yu X, Bao J, Cao NN, Li B, Si-Tu B.
    Rejuvenation Res; 2012 Aug; 15(4):423-34. PubMed ID: 22877565
    [Abstract] [Full Text] [Related]

  • 22. The APOM polymorphism as a novel risk factor for dyslipidaemia in rheumatoid arthritis: a possible shared link between disease susceptibility and dyslipidaemia.
    Park YJ, Yoo SA, Lee JH, Chung YJ, Cho CS, Kim W-.
    Clin Exp Rheumatol; 2013 Aug; 31(2):180-8. PubMed ID: 23190940
    [Abstract] [Full Text] [Related]

  • 23. Apolipoprotein M: Research progress, regulation and metabolic functions (Review).
    Huang LZ, Gao JL, Pu C, Zhang PH, Wang LZ, Feng G, Zhang Y.
    Mol Med Rep; 2015 Aug; 12(2):1617-24. PubMed ID: 25901639
    [Abstract] [Full Text] [Related]

  • 24. Estrogen upregulates hepatic apolipoprotein M expression via the estrogen receptor.
    Wei J, Shi Y, Zhang X, Feng Y, Luo G, Zhang J, Mu Q, Tang Y, Yu Y, Pan L, Nilsson-Ehle P, Xu N.
    Biochim Biophys Acta; 2011 Dec; 1811(12):1146-51. PubMed ID: 21816233
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma.
    Axler O, Ahnström J, Dahlbäck B.
    J Lipid Res; 2007 Aug; 48(8):1772-80. PubMed ID: 17526892
    [Abstract] [Full Text] [Related]

  • 29. Correlation analysis between ApoM gene-promoter polymorphisms and coronary heart disease.
    Zhang Y, Huang LZ, Yang QL, Liu Y, Zhou X.
    Cardiovasc J Afr; 2016 Aug; 27(4):228-237. PubMed ID: 27841911
    [Abstract] [Full Text] [Related]

  • 30. Levels of apolipoprotein M are not associated with the risk of coronary heart disease in two independent case-control studies.
    Ahnström J, Axler O, Jauhiainen M, Salomaa V, Havulinna AS, Ehnholm C, Frikke-Schmidt R, Tybjaerg-Hansen A, Dahlbäck B.
    J Lipid Res; 2008 Sep; 49(9):1912-7. PubMed ID: 18490703
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of apolipoprotein M as a biomarker of coronary artery disease.
    Su W, Jiao G, Yang C, Ye Y.
    Clin Biochem; 2009 Mar; 42(4-5):365-70. PubMed ID: 19100249
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.
    Malave H, Castro M, Burkle J, Voros S, Dayspring T, Honigberg R, Pourfarzib R.
    Am J Cardiol; 2012 Sep 01; 110(5):662-5. PubMed ID: 22621796
    [Abstract] [Full Text] [Related]

  • 33. The MCP-1 Gene A-2518G Polymorphism Confers an Increased Risk of Vascular Complications in Type 2 Diabetes Mellitus Patients.
    Xu J, Liao YF, Zhou WP, Ming HL, Wang QH.
    Genet Test Mol Biomarkers; 2015 Aug 01; 19(8):411-7. PubMed ID: 26083329
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Low serum LDL cholesterol in patients with type 2 diabetes: an analysis on two different patient populations.
    Saely CH, Eber B, Pfeiffer KP, Drexel H, LIIFE-IN-LIFE study group.
    Int J Cardiol; 2010 Oct 29; 144(3):394-8. PubMed ID: 19477539
    [Abstract] [Full Text] [Related]

  • 36. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L, Buysschaert M, Hermans MP.
    J Clin Lipidol; 2012 Oct 29; 6(5):434-42. PubMed ID: 23009779
    [Abstract] [Full Text] [Related]

  • 37. Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells.
    Xu N, Hurtig M, Zhang XY, Ye Q, Nilsson-Ehle P.
    Biochim Biophys Acta; 2004 Jul 05; 1683(1-3):33-7. PubMed ID: 15238217
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus.
    Tan HC, Tai ES, Sviridov D, Nestel PJ, Ng C, Chan E, Teo Y, Wai DC.
    J Clin Lipidol; 2011 Jul 05; 5(6):467-73. PubMed ID: 22108150
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.